Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma.

In 171 people with early-stage lung cancer from TRACERx, NeXT Personal detected preoperative ctDNA in 81% of those with lung adenocarcinoma.

Nature MedicinePubMed 39806071DOI 10.1038/s41591-024-03216-y